BioCentury | Dec 9, 2013
Clinical News

Remofuscin regulatory update

...designation for Remofuscin to treat Stargardt's disease. The potassium-competitive acid blocker is in preclinical development. Katairo GmbH...
Items per page:
1 - 1 of 1
BioCentury | Dec 9, 2013
Clinical News

Remofuscin regulatory update

...designation for Remofuscin to treat Stargardt's disease. The potassium-competitive acid blocker is in preclinical development. Katairo GmbH...
Items per page:
1 - 1 of 1